Bio Consult ApS
APSActiveAdvertising protectionCVR 44293277Stigsborg Parkvej 83, 9400 NørresundbyEngineering activities and related technical consultancy· NACE 7112Est. 2023 · 3 years old— employees
Loading company…
Overview
Bio Consult ApS is a Danish APS based in Nørresundby, operating in the Engineering activities and related technical consultancy sector. Incorporated in 2023, the company reported revenue of DKK 0 in its latest annual filing.
Revenue 2025
0K DKK
EBITDA margin
—
Net profit 2025
-11.3K DKK
+25% vs 2024
Key ratios
See full ratios →Solidity ratioEquity ÷ Total assets × 100
100.0 %
Very strongAmong the 10% highest rated companies in the industry
20242025
Liquidity ratioCurrent assets ÷ Short-term debt
0.0×
20242025
Return on assets (ROA)Net profit ÷ Total assets × 100
-34.8 %
Very weakAmong the 20% lowest rated companies in the industry
20242025
EBITDA — year on year
DKK thousandsKey figures
Annual report 2025| Revenue | 0K DKK | — |
| EBITDA | -11.3K DKK | +25% |
| Net profit | -11.3K DKK | +25% |
| Total assets | 32.5K DKK | 0% |
| Equity | 32.5K DKK | +30% |
| Employees | — | — |
Company information
Legal name
Bio Consult ApS
CVR number
44293277
Legal form
Anpartsselskab
NACE code
Founded
11 September 2023 · 3 years
Share capital
DKK 40,000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af den samlede bestyrelse
Company purpose
Virksomhedens formål er salg af organiske bio stimulanser til landbrug og gartneri
(no translation available)
Contact
Address
Stigsborg Parkvej 83, 9400 Nørresundby
Phone
+45 2294 0464
Email
krag.michael@gmail.com
Advertising protection
Active — opted out of marketing use
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), Bio Consult ApS reported revenue of DKK 0. The figures on this page draw on 2 annual filings covering 2024 to 2025. The bottom line showed a net loss of DKK 11.3k.
At the end of 2025, equity financed 100% of the balance sheet.
Financials
Revenue
DKK thousandsEBITDA
DKK thousandsIncome statement
DKK thousands| Item | 2025 | 2024 |
|---|---|---|
| Revenue | 0 | -15 |
| Staff expenses | -0 | -0 |
| EBITDA | -11 | -15 |
| Depreciation & amort. | -0 | -0 |
| EBIT | -11 | -15 |
| Net financials | 0 | 0 |
| Profit before tax | -11 | -15 |
| Tax | -0 | -0 |
| Net profit | -11 | -15 |
Balance sheet
DKK thousands| Item | 2025 | 2024 |
|---|---|---|
| Total assets | 33 | 33 |
| Equity | 33 | 25 |
| Long-term debt | 0 | 0 |
| Short-term debt | 0 | 8 |
| Total debt | 0 | 8 |
Financial ratios
5-year trendEBITDA margin
<−999 %
20242025
Equity ratio
100.0 %
Very strongAmong the 10% highest rated companies in the industry
20242025
Return on equity
-34.8 %
Very weakAmong the 20% lowest rated companies in the industry
20242025
Net profit margin
<−999 %
20242025
Asset turnover
0.00×
Very weakAmong the 10% lowest rated companies in the industry
20242025
Debt / equity
0.00×
20242025
Sector performance
15 of 28 ratios graded28 financial ratios from the latest filing, each graded against companies in the same industry.
Profitability
Return on equity (ROE)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Return on assets (ROA)Very weak
Among the 20% lowest rated companies in the industry
Net profit as a percentage of total assets — the return generated on the capital employed.
Return on net assets (RONA)Very weak
Among the 20% lowest rated companies in the industry
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Basic earning power (BEP)Very weak
Among the 20% lowest rated companies in the industry
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Gross marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
Operating marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
Net profit marginNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Capacity ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
Liquidity
Current assets to equityStrong
Among the 30% highest rated companies in the industry
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets to long-term capitalVery strong
Among the 10% highest rated companies in the industry
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash conversion ratioWeak
Among the 40% lowest rated companies in the industry
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Quick ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Debt & solvency
Solidity ratioVery strong
Among the 10% highest rated companies in the industry
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Liabilities to equityVery strong
Among the 10% highest rated companies in the industry
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Interest rate on debtVery strong
Among the 10% highest rated companies in the industry
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
Interest marginVery weak
Among the 20% lowest rated companies in the industry
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt ratioNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt to equityNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Income to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA to debtNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
EBITDA relative to debt — how much operating earnings are available to service the debt.
Interest coverageNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
The ability to pay the interest on the company's debt out of its earnings.
Efficiency & development
Asset turnoverVery weak
Among the 10% lowest rated companies in the industry
Revenue relative to total assets — the ability to generate revenue from the asset base.
Equity to contributed capitalWeak
Among the 30% lowest rated companies in the industry
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
One-year change in equityStrong
Among the 30% highest rated companies in the industry
The size of this year's increase or decrease in the company's equity.
One-year change in debtVery strong
Among the 10% highest rated companies in the industry
The size of this year's increase or decrease in the company's debt.
Inventory turnoverNot rated
Cannot be graded — the figures this ratio builds on are not available in the latest filing.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
Annual reports & filings
People & ownership
Management
Actively employed in the business| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Management | Management | 2026 |
Former (2)
TB Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
JS Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
Board of directors
Non-executive oversight| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chairman | Chairman | 2024 |
Former (4)
CG Board of Directors | Board of Directors | 2023 – 2025 |
ET Board of Directors | Board of Directors | 2023 – 2025 |
TB Board of Directors | Board of Directors | 2023 – 2025 |
JS Chairman | Chairman | 2023 – 2024 |
Shareholders
Active legal owners| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Individual | 100% | 100% | 2026 | |
| Company | 100% | 100% | 2025 | |
| Company | 50–66.65% | 50–66.65% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Related companies
Company hierarchy
Aliga ApS
Bio Consult ApS Board network connections
Board members of Bio Consult ApS also hold positions in 13 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Torngaard Hansen | Board of Directors | 4 companies |
| Michael Krag Nielsen | Management | 3 companies |
| Christian Gommesen-Byrjalsen | Board of Directors | 3 companies |
| Jan Stagsted | Chief Executive Officer | 2 companies |
| Tonni Brammer Pedersen | Chief Executive Officer | 1 company |
Frequently asked questions
What is the CVR number of Bio Consult ApS?
Bio Consult ApS is registered with CVR / Virk under CVR 44293277.
Who is the chairman of Bio Consult ApS?
Michael Krag Nielsen chairs the board of Bio Consult ApS, in role since 2024.
Where is Bio Consult ApS headquartered?
Bio Consult ApS's registered address is Stigsborg Parkvej 83, 3. 1.